Multiple Sclerosis Trial, Recruiting NCT00001248 Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT00001248
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older who have been diagnosed with multiple sclerosis (MS), or who have brain scan or physical findings linked to MS.
  • Healthy volunteers aged 18 or older with no MS diagnosis.
  • People who are able to understand and sign a consent form agreeing to take part.

Who may not be able to join:

  • People who have a medical reason that prevents them from having an MRI scan at the time of joining the trial (note: pregnancy alone is not considered a disqualifying reason under this criterion — confirm with trial site).
  • People who are not willing to allow their anonymised (coded) samples to be sent to another location for testing, or who do not want their coded samples used in other research studies.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Daniel S Reich, M.D., National Institute of Neurological Disorders and Stroke (NINDS)

Phone: (301) 496-3825

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
23 July 1992

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

the rate of change in the number of new white matter lesions per participant

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov